DrugPatentWatch Database Preview
Septodont Holding Company Profile
What is the competitive landscape for SEPTODONT HOLDING, and when can generic versions of SEPTODONT HOLDING drugs launch?
SEPTODONT HOLDING has one approved drug.
There are five US patents protecting SEPTODONT HOLDING drugs.
There are thirty patent family members on SEPTODONT HOLDING drugs in twenty countries.
Summary for Septodont Holding
International Patents: | 30 |
US Patents: | 5 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Septodont Holding
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Septodont Holding | ORAVERSE | phentolamine mesylate | INJECTABLE;INJECTION | 022159-001 | May 9, 2008 | RX | Yes | Yes | 6,872,390 | ➤ Sign Up | Y | ➤ Sign Up | |||
Septodont Holding | ORAVERSE | phentolamine mesylate | INJECTABLE;INJECTION | 022159-001 | May 9, 2008 | RX | Yes | Yes | 7,575,757 | ➤ Sign Up | Y | ➤ Sign Up | |||
Septodont Holding | ORAVERSE | phentolamine mesylate | INJECTABLE;INJECTION | 022159-001 | May 9, 2008 | RX | Yes | Yes | 7,569,230 | ➤ Sign Up | ➤ Sign Up | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Septodont Holding Drugs
Country | Document Number | Estimated Expiration |
---|---|---|
South Africa | 200209811 | ➤ Sign Up |
Cyprus | 1107617 | ➤ Sign Up |
Japan | 2003532678 | ➤ Sign Up |
Country | Document Number | Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.